Back to About
Company News
Stay updated with the latest news, announcements, and developments from AbOliGo as we advance antibody-oligonucleotide conjugate technology.
Leadership
AbOliGo Welcomes Dr. Ed Ralph as Chief Technology Officer to Lead AI-Driven Panel Design
AbOliGo announces the appointment of Dr. Ed Ralph as Chief Technology Officer to lead development of AI-powered panel design platform.
By Brian Carpenter
Read full article
Funding
AbOliGo Closes Oversubscribed Round to Accelerate Multiomic Research Tools and Appoints Proven Life Sciences Board
AbOliGo announces successful close of oversubscribed seed funding round and formation of expert Board of Directors to accelerate AOC manufacturing and commercial growth.
By Brian Carpenter
Read full article